Tapewire

NYSE · USD

MRK

Merck & Co., Inc.

Export transactions ↓
Tapewire entity
2807
SEC CIK
0000310158
Parsed reports
1,951

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 2026016
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026017
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 12, 2018 Filed Jan 16, 2018 22:12 UTC SaleCommon Stock 5,000 $58.00 $290,000.00
Disclosure

SEC source: 0001225208-18-001052 · doc4.xml · nonDerivative · entry 1

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,484.319

F1 · kind: The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 12, 2018 Filed Jan 19, 2018 22:30 UTC Amendment SaleCommon Stock 8,000 $58.00 $464,000.00
Disclosure

SEC source: 0001225208-18-001321 · doc4a.xml · nonDerivative · entry 1

GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,484.319

F1 · kind: The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.

F2 · shares: The original Form 4, filed on January 16, 2018, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on January 12, 2018 as a total of 5,000 shares sold when in fact 8,000 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 3,000 shares, and includes shares acquired in dividend reinvestment transactions.

F2 · balance_after: The original Form 4, filed on January 16, 2018, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on January 12, 2018 as a total of 5,000 shares sold when in fact 8,000 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 3,000 shares, and includes shares acquired in dividend reinvestment transactions.

Read SEC document
December 29, 2017 Filed Jan 3, 2018 16:42 UTC GrantPhantom Stock · Derivative 577.5724 $56.27 $32,500.00
Disclosure

SEC source: 0001225208-18-000184 · doc4.xml · derivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,166.1644

Underlying: Common Stock · 577.5724 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 29, 2017 Filed Jan 3, 2018 16:42 UTC GrantPhantom Stock · Derivative 488.7151 $56.27 $27,500.00
Disclosure

SEC source: 0001225208-18-000185 · doc4.xml · derivative · entry 3

LAZARUS ROCHELLE B · CIK 0001082206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,338.3351

Underlying: Common Stock · 488.7151 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 29, 2017 Filed Jan 3, 2018 16:42 UTC GrantPhantom Stock · Derivative 488.7151 $56.27 $27,500.00
Disclosure

SEC source: 0001225208-18-000186 · doc4.xml · derivative · entry 2

Noseworthy John H · CIK 0001706596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,719.6771

Underlying: Common Stock · 488.7151 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 29, 2017 Filed Jan 3, 2018 16:42 UTC GrantPhantom Stock · Derivative 488.7151 $56.27 $27,500.00
Disclosure

SEC source: 0001225208-18-000187 · doc4.xml · derivative · entry 2

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,917.1181

Underlying: Common Stock · 488.7151 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 29, 2017 Filed Jan 3, 2018 16:42 UTC GrantPhantom Stock · Derivative 488.7151 $56.27 $27,500.00
Disclosure

SEC source: 0001225208-18-000188 · doc4.xml · derivative · entry 2

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,929.8731

Underlying: Common Stock · 488.7151 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
December 15, 2017 Filed Dec 18, 2017 18:56 UTC
Schechter Adam HEVP & Pres-Global Human Health
GiftCommon Stock 750 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-018771 · doc4.xml · nonDerivative · entry 1

Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 113,373.9747

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
November 09, 2017 Filed Nov 13, 2017 19:05 UTC
Chattopadhyay SanatExe V-P & Pres. MMD
OtherPhantom Stock · Derivative 13,099.521 $56.21 $736,324.08
Disclosure

SEC source: 0001225208-17-017206 · doc4.xml · derivative · entry 2

Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,122.638

Underlying: Common Stock · 13,099.521 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program.

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program.

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
November 08, 2017 Filed Nov 9, 2017 20:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $38.04 $0.00
Disclosure

SEC source: 0001225208-17-017141 · doc4.xml · derivative · entry 3

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2018-04-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option became exercisable in equal installments on 4/30/2009, 4/30/2010 and 4/30/2011.

Read SEC document
November 08, 2017 Filed Nov 9, 2017 20:52 UTC SaleCommon Stock 5,000 $56.20 $280,982.50
Disclosure

SEC source: 0001225208-17-017141 · doc4.xml · nonDerivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,100

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.1900 to $56.1981, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

Read SEC document
November 08, 2017 Filed Nov 9, 2017 20:52 UTC Exercise / conversionCommon Stock 5,000 $38.04 $190,200.00
Disclosure

SEC source: 0001225208-17-017141 · doc4.xml · nonDerivative · entry 1

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 29, 2017 Filed Oct 2, 2017 19:08 UTC GrantPhantom Stock · Derivative 507.5746 $64.03 $32,500.00
Disclosure

SEC source: 0001225208-17-015550 · doc4.xml · derivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,197.6646

Underlying: Common Stock · 507.5746 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 29, 2017 Filed Oct 2, 2017 19:08 UTC GrantPhantom Stock · Derivative 429.4862 $64.03 $27,500.00
Disclosure

SEC source: 0001225208-17-015551 · doc4.xml · derivative · entry 3

LAZARUS ROCHELLE B · CIK 0001082206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,326.1282

Underlying: Common Stock · 429.4862 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 29, 2017 Filed Oct 2, 2017 19:08 UTC GrantPhantom Stock · Derivative 429.4862 $64.03 $27,500.00
Disclosure

SEC source: 0001225208-17-015552 · doc4.xml · derivative · entry 2

Noseworthy John H · CIK 0001706596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,210.7112

Underlying: Common Stock · 429.4862 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 29, 2017 Filed Oct 2, 2017 19:08 UTC GrantPhantom Stock · Derivative 429.4862 $64.03 $27,500.00
Disclosure

SEC source: 0001225208-17-015553 · doc4.xml · derivative · entry 2

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,871.8132

Underlying: Common Stock · 429.4862 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
September 29, 2017 Filed Oct 2, 2017 19:08 UTC GrantPhantom Stock · Derivative 429.4862 $64.03 $27,500.00
Disclosure

SEC source: 0001225208-17-015554 · doc4.xml · derivative · entry 2

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,877.2472

Underlying: Common Stock · 429.4862 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 16:21 UTC GrantPhantom Stock · Derivative 507.0994 $64.09 $32,500.00
Disclosure

SEC source: 0001225208-17-012020 · doc4.xml · derivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,295.2079

Underlying: Common Stock · 507.0994 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 16:22 UTC GrantPhantom Stock · Derivative 429.0841 $64.09 $27,500.00
Disclosure

SEC source: 0001225208-17-012022 · doc4.xml · derivative · entry 3

LAZARUS ROCHELLE B · CIK 0001082206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,365.9976

Underlying: Common Stock · 429.0841 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 16:22 UTC GrantPhantom Stock · Derivative 143.0281 $64.09 $9,166.67
Disclosure

SEC source: 0001225208-17-012023 · doc4.xml · derivative · entry 2

Noseworthy John H · CIK 0001706596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,761.6356

Underlying: Common Stock · 143.0281 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 16:23 UTC GrantPhantom Stock · Derivative 429.0841 $64.09 $27,500.00
Disclosure

SEC source: 0001225208-17-012025 · doc4.xml · derivative · entry 2

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,877.9316

Underlying: Common Stock · 429.0841 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 16:23 UTC GrantPhantom Stock · Derivative 429.0841 $64.09 $27,500.00
Disclosure

SEC source: 0001225208-17-012026 · doc4.xml · derivative · entry 2

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,875.8996

Underlying: Common Stock · 429.0841 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010551 · doc4.xml · derivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,271.3795

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010552 · doc4.xml · derivative · entry 2

Cech Thomas R · CIK 0001464680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,344.7805

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010553 · doc4.xml · derivative · entry 2

Craig Pamela J. · CIK 0001232910 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,482.3845

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010554 · doc4.xml · derivative · entry 2

GLOCER THOMAS H · CIK 0001140799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,788.1085

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010555 · doc4.xml · derivative · entry 3

LAZARUS ROCHELLE B · CIK 0001082206 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,936.9135

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC
Rothman PaulDirector
GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010556 · doc4.xml · derivative · entry 2

Rothman Paul · CIK 0001601332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,482.3855

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010557 · doc4.xml · derivative · entry 2

REPRESAS CARLOS E · CIK 0001216083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,755.2025

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010558 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,773.1315

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010559 · doc4.xml · derivative · entry 2

Thompson Craig B. · CIK 0001423419 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,773.1335

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010560 · doc4.xml · derivative · entry 2

WEEKS WENDELL P · CIK 0001206158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,448.8475

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010561 · doc4.xml · derivative · entry 2

WENDELL PETER C · CIK 0001032635 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,446.8155

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 26, 2017 Filed May 30, 2017 21:33 UTC GrantPhantom Stock · Derivative 2,618.6075 $64.92 $170,000.00
Disclosure

SEC source: 0001225208-17-010562 · doc4.xml · derivative · entry 2

Noseworthy John H · CIK 0001706596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,618.6075

Underlying: Common Stock · 2,618.6075 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Read SEC document
May 12, 2017 Filed May 12, 2017 20:58 UTC Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $35.19 $0.00
Disclosure

SEC source: 0001225208-17-009615 · doc4.xml · derivative · entry 4

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2020-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013.

Read SEC document
May 12, 2017 Filed May 12, 2017 20:58 UTC SaleCommon Stock 5,000 $63.54 $317,695.00
Disclosure

SEC source: 0001225208-17-009615 · doc4.xml · nonDerivative · entry 2

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,317

Read SEC document
May 12, 2017 Filed May 12, 2017 20:58 UTC Exercise / conversionCommon Stock 5,000 $35.19 $175,950.00
Disclosure

SEC source: 0001225208-17-009615 · doc4.xml · nonDerivative · entry 1

KIDDER C ROBERT · CIK 0001179703 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
Davis Robert MEVP, Global Svcs & CFO
Exercise / conversionRestricted Stock Unit · Derivative 85,881 $64.01 $5,497,242.81
Disclosure

SEC source: 0001225208-17-009424 · doc4.xml · derivative · entry 4

Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 85,881 shares

Expires 2017-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
Davis Robert MEVP, Global Svcs & CFO
Tax withholdingCommon Stock 44,530 $64.01 $2,850,365.30
Disclosure

SEC source: 0001225208-17-009424 · doc4.xml · nonDerivative · entry 2

Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,500.943

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
Davis Robert MEVP, Global Svcs & CFO
Exercise / conversionCommon Stock 85,881 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-009424 · doc4.xml · nonDerivative · entry 1

Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,030.943

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
Exercise / conversionRestricted Stock Unit · Derivative 2,576 $64.01 $164,889.76
Disclosure

SEC source: 0001225208-17-009425 · doc4.xml · derivative · entry 5

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,576 shares

Expires 2017-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
Tax withholdingCommon Stock 960 $64.01 $61,449.60
Disclosure

SEC source: 0001225208-17-009425 · doc4.xml · nonDerivative · entry 2

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,708.329

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
Exercise / conversionCommon Stock 2,576 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-009425 · doc4.xml · nonDerivative · entry 1

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,668.329

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
Karachun Rita ASr. VP Fince-Global Controller
Exercise / conversionRestricted Stock Unit · Derivative 2,576 $64.01 $164,889.76
Disclosure

SEC source: 0001225208-17-009426 · doc4.xml · derivative · entry 5

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,576 shares

Expires 2017-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
Karachun Rita ASr. VP Fince-Global Controller
Tax withholdingCommon Stock 960 $64.01 $61,449.60
Disclosure

SEC source: 0001225208-17-009426 · doc4.xml · nonDerivative · entry 2

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,107.972

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 09, 2017 Filed May 9, 2017 20:42 UTC
Karachun Rita ASr. VP Fince-Global Controller
Exercise / conversionCommon Stock 2,576 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-009426 · doc4.xml · nonDerivative · entry 1

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,067.972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:42 UTC
Davis Robert MEVP, Global Svcs & CFO
GrantStock Option (right to buy) · Derivative 162,625 $0.00 Strike: $63.97 $0.00
Disclosure

SEC source: 0001225208-17-009424 · doc4.xml · derivative · entry 3

Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,625

Underlying: Common Stock · 162,625 shares

Expires 2027-05-04

F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:42 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
GrantStock Option (right to buy) · Derivative 21,398 $0.00 Strike: $63.97 $0.00
Disclosure

SEC source: 0001225208-17-009425 · doc4.xml · derivative · entry 4

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,398

Underlying: Common Stock · 21,398 shares

Expires 2027-05-04

F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:42 UTC
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
GrantRestricted Stock Unit · Derivative 2,345 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-009425 · doc4.xml · derivative · entry 3

AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,345

Underlying: Common Stock · 2,345 shares

Expires 2020-05-05

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:42 UTC
Karachun Rita ASr. VP Fince-Global Controller
GrantStock Option (right to buy) · Derivative 29,957 $0.00 Strike: $63.97 $0.00
Disclosure

SEC source: 0001225208-17-009426 · doc4.xml · derivative · entry 4

Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,957

Underlying: Common Stock · 29,957 shares

Expires 2027-05-04

F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal instllments on 5/5/2018, 5/5/2019 and 5/5/2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.